Global Hernia Mesh Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Mesh Type;

Biologic Mesh and Synthetic Mesh

By Hernia Type;

Inguinal, Femoral, Incisional, Umbilical, and Others

By Surgery;

Laparoscopic and Open Repair

By Mesh Material;

Absorbable Mesh and Non-Absorbable Mesh

By End-Use;

Hospitals, Ambulatory Surgical Centers, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn141064701 Published Date: May, 2025 Updated Date: June, 2025

Hernia Mesh Devices Market Overview

Hernia Mesh Devices Market (USD Million)

Hernia Mesh Devices Market was valued at USD 4,924.05 million in the year 2024. The size of this market is expected to increase to USD 5,974.12 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 2.8%.


Global Hernia Mesh Devices Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 2.8 %


Study Period2025 - 2031
Base Year2024
CAGR (%)2.8 %
Market Size (2024)USD 4,924.05 Million
Market Size (2031)USD 5,974.12 Million
Market ConcentrationHigh
Report Pages303
4,924.05
2024
5,974.12
2031

Major Players

  • B. Braun Melsungen AG
  • W. L. Gore & Associates, Inc.
  • Cook Medical LLC
  • Integra LifeSciences Holdings Corporation
  • Baxter International Inc.
  • Herniamesh S.r.l.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Hernia Mesh Devices Market

Fragmented - Highly competitive market without dominant players


The hernia mesh devices market is experiencing steady growth, largely driven by the increasing incidence of hernias and advancements in surgical treatment techniques. Hernia mesh implants have become the standard of care, used in over 90% of repair procedures due to their effectiveness in reducing recurrence and supporting faster recovery. This widespread adoption highlights the critical role these devices play in modern surgical practices.

Innovation Driving Growth
Technological advancements are significantly transforming the landscape of hernia repair. Manufacturers are developing lightweight, absorbable, and composite mesh products that offer improved compatibility with body tissues and fewer complications. Minimally invasive procedures, especially laparoscopic techniques, now represent more than 65% of hernia surgeries, with robotic-assisted methods adding further precision and reducing surgical risks.

Impact of Aging Population
The rise in the geriatric population. Older adults are particularly vulnerable to hernias due to muscle degeneration and chronic health conditions. Individuals aged 65 and above now account for approximately 40% of hernia repair procedures, emphasizing the need for advanced, reliable mesh solutions tailored to complex patient profiles.

Increasing Patient Awareness
There is a growing awareness among patients regarding the benefits of early surgical intervention and the advantages of mesh-based repair. Improved healthcare access and educational efforts have contributed to a notable shift in treatment preferences. As a result, satisfaction rates among patients undergoing mesh repairs have surpassed 85%, thanks to enhanced recovery times, reduced discomfort, and long-term procedural success.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Mesh Type
    2. Market Snapshot, By Hernia Type
    3. Market Snapshot, By Surgery
    4. Market Snapshot, By Mesh Material
    5. Market Snapshot, By End-use
    6. Market Snapshot, By Region
  4. Hernia Mesh Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Incidence of Hernias
        2. Technological Advancements in Mesh Design
        3. Aging Population
        4. Rising Demand for Minimally Invasive Procedures
        5. Growing Adoption of Mesh Repair Techniques
      2. Restraints
        1. Complications Associated with Mesh Implantation
        2. Regulatory Scrutiny and Safety Concerns
        3. High Cost of Mesh Devices
        4. Lack of Reimbursement Policies in Developing Countries
        5. Surgical Expertise and Training Requirements
      3. Opportunities
        1. Emerging Markets and Untapped Regions
        2. Development of Biologic Meshes and Bioresorbable Materials
        3. Expansion of Indications for Hernia Mesh Devices
        4. Patient Education and Awareness Initiatives
        5. Collaborations and Partnerships for Product Development
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Hernia Mesh Devices Market, By Mesh Type, 2021 - 2031 (USD Million)
      1. Biologic Mesh
      2. Synthetic Mesh
    2. Hernia Mesh Devices Market, By Hernia Type, 2021 - 2031 (USD Million)
      1. Inguinal
      2. Femoral
      3. Incisional
      4. Umbilical
      5. Others
    3. Hernia Mesh Devices Market, By Surgery, 2021 - 2031 (USD Million)
      1. Laparoscopic
      2. Open Repair
    4. Hernia Mesh Devices Market, By Mesh Material, 2021 - 2031 (USD Million)
      1. Absorbable Mesh
      2. Non-Absorbable Mesh
    5. Hernia Mesh Devices Market, By End-use, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Others
    6. Hernia Mesh Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Novartis
      2. Bayer
      3. Merck & Co.
      4. Bristol-Myers Squibb
      5. AbbVie
      6. Johnson & Johnson
      7. Celgene
      8. Amgen
      9. Teva Pharmaceutical Industries
      10. Pfizer
      11. Takeda Pharmaceutical Company
  7. Analyst Views
  8. Future Outlook of the Market